April 27, 2021 – Abbott (Abbott Park, IL) announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe.
This imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization.
The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.
Unlike traditional imaging methods such as conventional angiography, Abbott’s OCT technology uses near-infrared light to provide high-definition, precise imaging from within a blood vessel, the company says.
Through integration with Abbott’s new Dragonfly OpStar imaging catheter, Ultreon Software extends the reach of OCT by allowing physicians to capture information from even the most complex patient anatomy.
Abbott also intends to seek approval in the U.S. and Japan.